1. Introduction {#sec1}
===============

Endogenous endophthalmitis can occur in immunocompromised patients.[@bib1] For this patient population, the source is often fungal and the most common species is Candida.[@bib2] Here, we present a unique case of endogenous fungal endophthalmitis caused by the rare organism *Exophiala* (previously *Wangiella) dermatitidis.*

2. Case report {#sec2}
==============

A 67-year-old man was transferred to our institution from an inpatient rehab facility with a two-day history of rapidly progressing redness and irritation of the right eye with periorbital edema. His past medical history is significant for hairy cell leukemia and recent acute ischemic left anterior cerebral artery stroke. Of note, he had been receiving chemotherapy from a peripherally inserted central catheter (PICC) for two months. The patient had no known previous ocular history or surgery. On physical exam, the patient had altered mental status and was nonverbal. Ophthalmic exam of the right eye (OD) revealed light perception visual acuity, restricted motility in all directions, significant periorbital erythema, and marked chemosis with necrosis of the inferior conjunctiva due to exposure ([Fig. 1](#fig1){ref-type="fig"}). The left eye (OS) was unremarkable. On funduscopic exam there was no red reflex appreciated OD and cotton wool spots were noted in the periphery OS. B-scan ultrasound OD showed dense vitreous debris, choroidal effusions, and thickened sclera with T-sign. MRI of brain was remarkable for acute on subacute infarcts of the bilateral anterior cerebral arteries and proptosis of the right eye with marked edema.Fig. 1Marked necrotic chemosis of the right eye.Fig. 1

Endogenous panophthalmitis was considered the most likely diagnosis given the patient\'s immunocompromised status secondary to chemotherapy and history of leukemia and long-term indwelling PICC line. A bacterial source was suspected considering the rapid onset of symptoms, but fungal source remained high on the differential.

The patient underwent a vitreous tap with intravitreal injection of vancomycin (1 mg/ 0.1 mL), ceftazidime (2.25 mg/ 0.1 mL), and voriconazole (100 mcg/ 0.1 mL) and was admitted for further work up. Cultures of vitreous fluid and blood showed no growth. A chest X-ray and transthoracic echocardiogram revealed no source of infection. The patient was started empirically on systemic vancomycin and cefepime along with topical prednisolone forte, atropine, and erythromycin ointment.

Given minimal improvement, the patient underwent 3 additional rounds of repeat vitreous tap and injection vancomycin/ceftazidime/voriconazole/amphotericin B as well as systemic voriconazole. After 15 days, cultures of vitreous fluid obtained by vitreous tap grew a rare fungal organism, *E. dermatitidis*. The patient also had an elevated Fungitell β-D Glucan assay of 207pg/mL making contamination less likely. Further work up with transesophageal echocardiogram revealed no source of infection. Three weeks after initial presentation, the patient showed no improvement in visual acuity of light perception and continued dense vitritis OD. The patient subsequently underwent cataract extraction and pars plana vitrectomy with silicone oil OD. Intraoperatively, the patient had notable retinal abscesses involving the superior hemi-retina. The retina overlying the abscess was found to be thin and necrotic. Inspection of the peripheral retina demonstrated retinal detachment from areas of retinal necrosis due to the infection. The areas of retinal necrosis were focally detached and all vitreous traction was relieved. Given the friable nature of the necrotic retina and the subretinal abscesses in areas of attached retina, the decision was made not to excise the abscesses or perform retinectomy of the superior retina as this would have involved excising the macula. Nondilute vitreous fluid cultures at the time of vitrectomy confirmed the presence of *E. dermatitidis*.

The patient was followed closely post-operatively and received one additional intravitreal injection of voriconazole/amphotericin B as well as oral voriconazole. The patient received a total of five rounds of intravitreal injections and 37 days of oral voriconazole treatment. His visual acuity gradually improved to hand motion and he was discharged to a nursing facility. Unfortunately, the patient experienced sudden cardiac death seven weeks after initial presentation and expired.

3. Discussion {#sec3}
=============

We present a unique case of *Exophiala* (previously known as *Wangiella*) *dermatitidis* endogenous endophthalmitis in an immunocompromised patient. Given the rapid progression of symptoms, the source was initially thought to be bacterial rather than fungal. Two weeks after initial presentation, vitreous fluid cultures grew a rare fungal organism, *E. dermatitidis*.

*Exophiala* species are dimorphic dematiaceous fungi. Our organism of interest, *E. dermatitidis,* was found to be the most prevalent Exophiala species identified clinically in the United States.[@bib3] Infections by *Exophiala* species are most commonly seen in deep tissues, especially the lungs, or cutaneous tissues. Intraocular infections are rare and comprise only 6.8% of infections caused by *Exophiala* species.[@bib3]

To date, there are no previous reports of endogenous endophthalmitis caused by *E. dermatitidis* in the literature. Most cases of endogenous fungal endophthalmitis are due to *Candida* infection[@bib1]^,^[@bib2] and *Exophiala* is an extremely rare organism to cause endophthalmitis.[@bib3]^,^[@bib4] Of the four cases reported of *E. dermatitidis* endophthalmitis, all were exogenous in nature occurring in patients with a history of ocular surgery.[@bib4], [@bib5], [@bib6], [@bib7] Two of the cases reported involvement of the cornea[@bib6]^,^[@bib7] and only one had presence of retinal abscesses as demonstrated in our case.[@bib6]

Voriconazole is the current treatment of choice in the treatment of *E. dermatitidis*.[@bib8] Of the cases reported of *E. dermatitidis* endophthalmitis, two cases had improvement with a combination of surgical intervention, voriconazole, and fluconazole treatment[@bib4]^,^[@bib7] and the other two cases resulted in enucleation.[@bib5]^,^[@bib6]

4. Conclusion {#sec4}
=============

This case illustrates the organism *E. dermatitidis* as an unusual cause of fungal endogenous endophthalmitis with rapid progression to panophthalmitis. Rare fungal organisms must be considered as a causative agent of endogenous endophthalmitis, particularly in immunocompromised hosts who fail standard therapy.
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